Surprisingly, businesswire.com at times has useful items on CRC
coloCan
Member Posts: 1,944 Member
such as that of 1/18 pertaining to a Phase I clinicl trial at Johns Hopkins Univ Hosp, Duke Univ Med Center and North Shore Long Island Jewish Med Center for NPC-1C-Ensituximab--
"Data on Neogenix Oncology's Novel Therapeutic Antibody NPC-1C.........."
Today, this site carried an article titled "Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With Folfox", which some might find informative.......steve
"Data on Neogenix Oncology's Novel Therapeutic Antibody NPC-1C.........."
Today, this site carried an article titled "Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With Folfox", which some might find informative.......steve
0
Comments
-
Very interesting read thanks
Enjoyed learning about this, thanks for posting it hear.
cheers,
Pete0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 793 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards